This content is restricted.
Brief
The List of Spurious Drugs for October 2024, published by CDSCO, highlights three pharmaceutical products—Pantoprazole & Domperidone Capsules, Cefixime Tablets, and Rosuvastatin Tablets—as potentially spurious. The manufacturers listed on the labels have denied producing these batches, raising concerns about counterfeit medications in circulation. Investigations are ongoing to confirm their authenticity and determine further regulatory actions.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested